Afghanistan launches nationwide polio vaccination campaign to immunise 7.3 million children
The four-day campaign, which commenced on Monday, will cover 187 districts, according to Sharafat Zaman Amarakhail, spokesperson for the ministry.
"A sub-national polio vaccination campaign has begun in 19 provinces of the country, covering 187 districts, and will continue for four days. Around 7.3 million children under the age of five will be vaccinated during this campaign," said Amarakhail in a statement to Tolo News.
Vaccination teams have spread throughout the streets, alleyways, and neighbourhoods of Kabul and other provinces, working to immunise children against the debilitating disease.
Noor Hussain, one of the vaccinators, shared his experience of the day's efforts: "I started my work at 7 a.m. The public's cooperation in bringing their children for vaccination was truly commendable."
As the vaccination campaign continues, residents in Kabul have called for the expansion of such initiatives to combat polio effectively.
Ramazan, a Kabul resident, emphasised the importance of spreading awareness, urging the government to educate people about the life-saving benefits of the vaccine. "We urge the government to educate people about the benefits of the vaccine and to continue this process," he told Tolo News.
Doctors have underscored the critical role of public awareness and continued investment in eradicating polio. Dr. Mojtaba Sufi, a local health expert, reiterated: "The only effective way to prevent polio is through vaccination, and these vaccines are provided by the international community."
The World Health Organization (WHO) reported over twenty positive cases of polio in Afghanistan last year.
However, the Ministry of Public Health has contested the accuracy of these figures, calling them "inaccurate."
The campaign is part of Afghanistan's ongoing efforts to fight polio and protect the health of its youngest citizens.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times of Oman
5 days ago
- Times of Oman
Pharma businesses ready with contingency plans faced with US tariffs: Association of Healthcare Providers (India)
New Delhi: Indian pharmaceutical manufacturers are preparing a two-pronged strategy to offset the impact of the soon-to-be-effective 25 per cent US tariff on Indian goods, which includes drug exports, with industry experts anticipating that the move could significantly raise medicine costs in the American market. Girdhar Gyani, Director General of the Association of Healthcare Providers (India), has voiced concern over the financial burden the proposed US tariff would impose on both Indian exporters and American consumers. India currently supplies around 47 per cent of the US pharmaceutical market, largely in the form of affordable generics. "If the United States enforces this 25 per cent tariff, the cost of drug delivery in the US will inevitably rise. Our estimates show that American drug prices could increase by 20 to 25 per cent annually -- a burden of nearly USD 6 to USD 7 billion. It's unclear whether the US healthcare system can absorb such an impact," Gyani said. According to its website, the Association of Healthcare Providers (India) , a non-profit organisation, represents the majority of healthcare providers in India. Despite the initial blow to Indian manufacturers, Gyani stated that industry players are already preparing contingency plans. One such measure is ramping up production in US-based and Mexico-based facilities owned by Indian firms, which, according to Gyani, would bypass the tariff restrictions. "The second approach involves a shift in focus from basic generics to value-added combination drugs. These combination drugs, which offer the convenience of two medicines in one, can be priced higher despite having similar production costs," he noted. The goal is to increase the volume and price range of such drugs, thereby maintaining competitiveness even under the new tariff regime. Gyani also suggested that continued diplomatic engagement between New Delhi and Washington could help mitigate the situation. "Negotiations between the two governments are likely to continue, and we may eventually see a reduction or reconsideration of the tariff policy," he said. The executive order signed by President Donald Trump on Thursday has imposed a flat 25 per cent tariff on all goods from India, with no product-level exemptions. The pharmaceutical sector has been a key pillar of India-US trade relations.
Times of Oman
5 days ago
- Times of Oman
S Korea eyeing Indian healthcare professionals to address ageing crisis
New Delhi: South Korea is looking to India's healthcare professionals to help tackle its looming demographic crisis, as the country fast becomes one of the world's oldest societies, Lim Sang Woo, Charge d'Affaires at the Korean Embassy here, said on Friday. With life expectancy in Korea projected to reach 87.2 years by 2040, the diplomat said the country is simultaneously battling the world's lowest fertility rate, which stands at 0.72. Pointing to India's demographic strength, Lim said, "You are the most populous country in the world, and you don't have low birth rate problems like us. You have a lot of talents. Why don't we have all these great Indian people in Korea? We have schools shutting down because there are no more students, and I know there are a lot of great healthcare personnel in India. Why not let them come to Korea?" He was speaking at the National Conference on Ageing in India. Outlining his country's efforts, Lim said Seoul has rolled out five-year plans since 2006 to tackle both low birth rates and ageing. Policies include up to three years of parental leave for both parents, subsidised childcare, housing support for newlyweds, and financial incentives such as Incheon city's scheme that provides families up to USD 72,000 per child until they turn 18. On support for the elderly, Lim highlighted universal healthcare, contributory and non-contributory pensions, and a long-term care insurance scheme launched in 2008 to provide home and daycare services. Pilot projects for integrated community-based care are also being rolled out. Despite these efforts, Lim admitted that results remain limited. "We had some short-term results at best... last year we saw an increase from 0.72 to 0.75, the first in nine years, but we still have a long way to go." The session, chaired by NITI Aayog member Dr Vinod K Paul, was part of the inaugural of Shaping Futures: Preparing for an Ageing Society, organised by Sankala Foundation with support from NITI Aayog, the Ministry of Social Justice and Empowerment, and NHRC.
Times of Oman
28-07-2025
- Times of Oman
NRIs turning to India for high-quality and affordable healthcare, patients up 150% YoY in FY25: Report
New Delhi: Non-Resident Indians (NRIs) are increasingly choosing India as their destination for high-quality and affordable healthcare, according to the data released by Policybazaar. The data showed a significant 150 per cent growth in the share of NRI customers in FY 2024-25 compared to FY 2023-24, highlighting India's growing appeal in the global medical tourism space. It stated, "India is fast emerging as one of the world's most sought-after medical tourism hubs. The growth is quite visible with more NRIs turning to India to access high-quality healthcare. Our data indicates a 150 per cent overall growth in the share of NRI customers in FY 25". One of the key reasons behind this mentioned in the data report is the surge is the massive cost advantage India offers for medical treatments when compared to countries like the United States and the United Kingdom. For instance, heart bypass surgery in India costs between USD 5,000 and USD 8,000, while the same procedure in the U.S. can cost between USD 70,000 and USD 150,000. Similarly, a knee replacement surgery costs only USD 4,000 to USD 6,000 in India, compared to USD 30,000 to USD 50,000 in the U.S. A liver transplant in India is priced between USD 25,000 and USD 35,000, whereas it costs USD 300,000 to USD 500,000 in the U.S. NRIs opting for elective procedures in India typically have average claim amounts ranging from USD 2,000 to USD 15,000. For more complex surgeries, the claims may rise to USD 20,000 to USD 40,000, still representing considerable savings when compared to international healthcare costs. The affordability factor also extends to health insurance premiums. In India, the average annual health insurance premium per person ranges from USD 120 to USD 300. In contrast, the same coverage in the U.S. can exceed USD 8,000 annually, while in GCC countries, it ranges from USD 4,000 to USD 5,000. This significant difference has led to a visible increase in online searches by NRIs exploring health insurance options in India for themselves and their families. The data further reveals a 125 per cent surge in the share of women NRI customers and a 148 per cent increase in the number of NRI customers under the age of 35. This showed that younger NRIs and women are increasingly considering Indian healthcare as a preferred choice. When it comes to preferred locations for treatment, South Indian cities continue to dominate the list across all tiers. Cities like Mumbai, Kolkata, Pune, and Thane are also gaining popularity among NRI patients.
